It has been about a month since the last earnings report for CRISPR Therapeutics AG (CRSP) . Shares have added about 3.3% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is CRISPR Therapeutics due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its latest earnings report in order to get a better handle on the important drivers.Narrower-Than-Expected Loss in Q3, ...